سعر Meloxicam 15 mg suppositories (Amriya) 2026

Generic meloxicam 15 mg rectal suppositories, 5 suppositories (Amriya Pharmaceutical Industries, Egypt); oxicam NSAID for rheumatic conditions.

• Long-term symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis.Population: AdultsIrish Medicines Board (now Health Products Regulatory Authority, HPRA)

• Children and adolescents under 16 years; third trimester of pregnancy.International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)
• History of proctitis or rectal bleeding (suppository route).International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)
• Hypersensitivity to meloxicam, excipients, aspirin or other NSAIDs (asthma, nasal polyps, angioedema or urticaria).International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)

• Use the lowest effective dose for the shortest duration; risks include gastrointestinal bleeding, ulceration or perforation, cardiovascular and cerebrovascular thrombotic events, serious skin reactions and renal impairment; avoid concomitant NSAIDs.International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)

• Oral anticoagulants, heparin, thrombolytics, antiplatelets, SSRIsIncreased risk of bleeding; combination not recommended or requires close monitoring.Irish Medicines Board (now Health Products Regulatory Authority, HPRA)
• Lithium, methotrexateNSAIDs may increase lithium and methotrexate levels; monitoring is advised.Irish Medicines Board (now Health Products Regulatory Authority, HPRA)

• Avoid in the first and second trimesters unless clearly necessary; contraindicated in the third trimester (risk of premature closure of the ductus arteriosus, renal dysfunction, prolonged bleeding and delayed labour).International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)
• NSAIDs pass into breast milk; administration is not recommended in women who are breastfeeding.International label, same formulation · Irish Medicines Board (now Health Products Regulatory Authority, HPRA)

• Meloxicam: Oxicam NSAID with anti-inflammatory, analgesic and antipyretic properties; inhibits prostaglandin biosynthesis.